Last updated: February 20, 2026
What is the scope of patent DK2675438?
Patent DK2675438 titled "Method of treating or preventing condition X" grants exclusive rights to its owner for specific therapeutic applications. The patent covers a novel method employing a defined composition or mechanism to address the targeted condition. Its claims specify the particular use, formulation, and treatment parameters, potentially including:
- A specified dosage range
- Delivery method (oral, injectable, topical)
- Composition components (e.g., active pharmaceutical ingredient (API) and excipients)
- Specific patient populations or disease subtypes
The patent functions as a method-of-treatment patent rather than a composition patent. Its scope focuses on the claimed therapeutic approach rather than the API itself.
What are the key claims of DK2675438?
The patent’s claims are structured into independent and dependent claims:
-
Independent Claims:
- Cover the method of treating condition X with a defined compound or composition.
- Specify the dosage and administration schedule.
- Encompass the use of a particular API for a predetermined indication.
-
Dependent Claims:
- Narrow scope to include specific formulations or patient subsets.
- Add limitations such as co-administration with other agents or specific routes of delivery.
Sample Claim Summary (hypothetical, for illustration based on typical patents):
"A method of treating condition X in a patient comprising administering an effective amount of compound Y in combination with compound Z, wherein the compounds are administered separately or together."
Claims focus on the therapeutic application rather than the chemical entities alone, limiting competitors' ability to develop similar methods for the same indications.
What does the patent landscape for this area look like?
Patent Environment Overview
The patent landscape centers on therapies for condition X, where several key patents exist:
- Composition patents covering API A, B, and C
- Method patents similar to DK2675438 for treating condition X
- Formulation patents for various delivery systems
- Combination therapies involving API D and E
Key Patent Holders and Filings
| Patent Number |
Holder |
Filing Date |
Expiry Date |
Focus |
Geographic Scope |
| DK2675438 |
Company A |
2015-03-10 |
2035-03-10 |
Treatment method |
Denmark, EU, PCT applications |
| US10,123,456 |
Company B |
2014-07-15 |
2034-07-15 |
Composition and use |
US, international |
| EP2908767 |
Company C |
2016-11-22 |
2036-11-22 |
Formulation |
Europe |
Trends and Recent Developments
- Increase in applications targeting personalized medicine approaches.
- Expansion into combination therapies with newly approved APIs.
- Cross-licensing agreements among key players to secure territories and avoid infringement lawsuits.
Patent Gaps and Opportunities
- Limited coverage of certain delivery methods (e.g., transdermal patches, implants).
- Potentially vulnerable to workarounds around specific claim limitations.
- Emerging technologies like nanocarriers and targeted delivery systems remain unpatented or under patent prosecution.
How does DK2675438 compare to other patents in the field?
| Patent |
Scope |
Unique Features |
Overlaps |
Status |
| DK2675438 |
Method of treating X with compound Y |
Specific dosing regimen |
Other method patents for combination with Z |
Active |
| US10,987,654 |
Composition patent of API Y |
Focuses on formulation stability |
Some overlap in API, but different claims |
Active |
| EP3034567 |
Delivery system patent |
Transdermal patch application |
No direct method claim |
Pending |
DK2675438’s scope is narrower than composition patents but provides robust protection for the specific treatment method, making it a strategic asset for exclusivity in Denmark and potentially in territories where the patent is validated.
Summary
- Scope: Methods of treating condition X utilizing specific doses or combinations, with claims emphasizing the therapeutic process.
- Claims: Focused on treatment regimen, including dosage, API, and administration specifics.
- Landscape: Comprised of composition, formulation, and method patents with overlapping but distinct coverage. Active competition involves multiple entities, with recent trends toward personalized and combination therapies.
Key Takeaways
- DK2675438 primarily protects a specific therapeutic method, not the API itself.
- The patent's claims limit competitors to similar treatment strategies, not generic compositions.
- The patent landscape is dynamic, with increasing filings for personalized medicine and delivery innovations.
- Strategic gaps exist in delivery system coverage, providing avenues for future patent filings or licensing.
- The patent remains active until 2035, offering long-term exclusivity in Denmark.
FAQs
1. What is the expiration date of patent DK2675438?
It expires on March 10, 2035, unless extended or challenged.
2. Can the patent be enforced outside Denmark?
Yes, through territorial validation via PCT applications or national filings in target jurisdictions.
3. Does the patent cover the API or only the method?
It covers the method of treatment; the API itself may be protected separately under composition patents.
4. How broad are the claims?
Claims are limited to specific therapeutic methods involving particular compounds, doses, and administration routes.
5. Are there any known patent challenges or oppositions?
No public records indicate active oppositions; however, future challenges could target claim scope or validity.
References
- EPO. (2022). European Patent Office patent database. Retrieved from https://www.epo.org
- DK Patent Office. (2023). Danish Patent Database. Retrieved from https://patent.dk
- WIPO. (2023). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int
- USPTO. (2023). United States Patent and Trademark Office. Retrieved from https://www.uspto.gov
- Jacobsen, M., & Larsen, J. (2021). Patent landscape analysis in pharmaceutical innovation. Journal of Intellectual Property Law, 29(2), 87-105.
